Video Experimental Relacionado
Updated: Dec 19, 2025
10:33
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.7K
El inhibidor de CDK CR8 actúa como un degradador de pegamento molecular que agota la ciclina K
Mikołaj Słabicki1,2,3, Zuzanna Kozicka4,5, Georg Petzold4
1Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nature
|June 5, 2020
Resumen
Los investigadores descubrieron un nuevo método para encontrar los degradantes moleculares del pegamento, que son medicamentos que eliminan las proteínas que causan enfermedades. Identificaron a CR8, un inhibidor de la cinasa dependiente de la ciclina (CDK), como un nuevo pegamento molecular que degrada la ciclina K, ofreciendo una nueva estrategia para el descubrimiento de fármacos.
Área de la Ciencia:
- La bioquímica
- Farmacología
- En el campo de la oncología
Sus antecedentes:
- Los pegamentos moleculares son compuestos que inducen la degradación de las proteínas mediante el secuestro de la maquinaria de la ubiquitina ligasa E3.
- Estos degradantes ofrecen una estrategia terapéutica prometedora para dirigirse a proteínas previamente no farmacológicas.
- Los métodos actuales de descubrimiento de pegamentos moleculares son en gran medida fortuitos, lo que limita su aplicación clínica.
Objetivo del estudio:
- Identificar sistemáticamente los nuevos degradantes moleculares del pegamento a través de la minería de bases de datos.
- Investigar el mecanismo por el cual CR8 funciona como un pegamento molecular.
- Establecer una estrategia más amplia para convertir los inhibidores existentes en pegamentos moleculares.
Principales métodos:
- Minería sistemática de conjuntos de datos a gran escala que correlacionan la citotoxicidad de pequeñas moléculas con la expresión de la ligasa E3 en líneas celulares cancerosas.
- Ensayos bioquímicos para elucidar la interacción entre CR8, CDK12-ciclina K y DDB1.
- Estudios de degradación de proteínas para confirmar la ubicuidad y el aclaramiento de la ciclina K.
Principales resultados:
- Identificación de CR8, un inhibidor de la cinasa dependiente de la ciclina (CDK), como nuevo degradador molecular del pegamento.
- CR8 induce un complejo ternario que involucra CDK12- ciclina K y DDB1, lo que lleva a la degradación de la ciclina K sin un receptor de sustrato.
- Demostración de que la modificación química de los inhibidores puede crear propiedades moleculares de pegamento.
Conclusiones:
- CR8 representa un nuevo degradador de pegamento molecular con aplicaciones terapéuticas potenciales.
- El estudio presenta un enfoque sistemático para el descubrimiento de pegamentos moleculares.
- La modificación de los inhibidores existentes ofrece una estrategia viable para desarrollar nuevos degradantes moleculares de pegamento.
Videos de Conceptos Relacionados
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
00:50Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
02:39Positive Regulator Molecules
6.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
01:45Positive Regulator Molecules
132.9K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
132.9K
02:15M-Cdk Drives Transition Into Mitosis
6.1K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.1K
02:17Separation of Sister Chromatids
4.2K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.2K